Efficacy, Safety and Immunogenicity of Anti-SARS-CoV-2 Vaccines in Patients with Cirrhosis: A Narrative Review

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causing coronavirus disease 2019 (COVID-19), has led to a pandemic with more than 6.5 million deaths worldwide. Patients with liver cirrhosis (PWLC) are regarded as prone to severe COVID-19. Vaccination against SARS-CoV-2 has been proven t...

Descripción completa

Detalles Bibliográficos
Autores principales: Toutoudaki, Konstantina, Dimakakou, Melitini, Androutsakos, Theodoros
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9966438/
https://www.ncbi.nlm.nih.gov/pubmed/36851329
http://dx.doi.org/10.3390/vaccines11020452

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9966438/
https://www.ncbi.nlm.nih.gov/pubmed/36851329
http://dx.doi.org/10.3390/vaccines11020452

Ejemplares similares